IP Library › Granted Patent US 8,247,210
Granted Patent B2
US 8,247,210 · App. 12/785,371 · Granted Aug 21, 2012

Host cells comprising alpha 1,2 mannosidase and culture methods thereof

Assignee: Amgen Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,247,210
App. No.
12/785,371
Granted
Aug 21, 2012
Kind
B2
Abstract

Improved host cells and culture methods involving overexpression of MAN1C1 activity to improve protein production are provided.

Claims (14)

1. An isolated host cell engineered to overexpress (a) alpha 1,2 mannosidase (MAN1C1) native to the host cell and (b) a glycoprotein of interest, wherein the MAN1C1 polypeptide is expressed at a level that increases specific productivity (pg/cell/day) of said glycoprotein of interest compared to an unaltered host cell.

2. The host cell of claim 1 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding MAN1C1 operably linked to a heterologous expression control sequence.

3. The host cell of claim 1 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding MAN1C1.

4. The host cell of any of claims 1 - 3 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding said glycoprotein of interest operably linked to a heterologous expression control sequence.

5. The host cell of any of claims 1 - 3 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding said glycoprotein of interest.

6. The host cell of claim 5 wherein the glycoprotein of interest is an erythropoiesis-stimulating molecule.

7. The host cell of claim 6 wherein the glycoprotein of interest is erythropoietin of SEQ ID NO: 3.

8. The host cell of claim 6 wherein the glycoprotein of interest is darbepoetin of SEQ ID NO: 5.

9. The host cell of claim 5 which is a mammalian cell.

10. The host cell of claim 5 which is a CHO cell.

11. The host cell of claim 5 which is a human cell.

12. The host cell of claim 5 which is a BHK cell.

13. The host cell of claim 5 which is an NS/0 cell.

14. The host cell of claim 5 which is an HT-1080 cell.

Continuity (3)
Continuation 11634757 · Dec 6, 2006
Provisional Application 60749076 · Dec 8, 2005
Related Publication 20110020811A1 · Jan 27, 2011